GlassScriptPhysician profile
Eric Thomas Roslonski
NPI 1730147273
$8,150.71
in general payments reported to CMS, 2019-2025
35 companies · $1,138 in 2025
The $1,138 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,200 · 2020: $1,030 · 2021: $1,557 · 2022: $538 · 2023: $1,246 · 2024: $1,442 · 2025: $1,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,825.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $3,319.19 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $840.97 | 2019-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $812.42 | 2019-2024 | Octrode |
| Nevro Corp. | $694.69 | 2019-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $540.50 | 2019-2025 | Relistor |
| Uswm, LLC | $182.76 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $161.49 | 2019-2021 | |
| Pfizer INC. | $156.59 | 2019-2021 | |
| Mdd US Operations, LLC | $151.33 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $148.65 | 2019-2024 | Ztlido |
| Pacira Therapeutics, INC. | $121.60 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $110.27 | 2024-2025 | |
| Abbvie INC. | $107.28 | 2019-2023 | Ubrelvy |
| Boston Scientific Corporation | $104.60 | 2020-2025 | General - Pain Management |
| Virtus Pharmaceuticals LLC | $95.09 | 2024-2025 | Levorphanol Tartrate |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $69.72 | 2019-2020 | |
| Lilly USA, LLC | $66.33 | 2020-2021 | |
| Amgen INC. | $53.12 | 2019-2022 | |
| Medtronic USA, INC. | $52.06 | 2019 | |
| Medtronic, INC. | $48.73 | 2022-2023 | Intellis Adaptivestim |
| Assertio Therapeutics, INC. | $43.23 | 2019-2020 | |
| Vertiflex, INC. | $41.02 | 2019 | |
| Spinal Simplicity, LLC | $25.83 | 2022 | |
| Globus Medical, INC. | $23.86 | 2025 | Senza |
| Nalu Medical, INC. | $21.45 | 2021 | |
| Allergan, INC. | $21.41 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.43 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.27 | 2019 | |
| Avanos Medical | $17.20 | 2025 | Generator |
| Relievant Medsystems, INC. | $16.55 | 2021 | |
| Daiichi Sankyo INC. | $15.62 | 2019 | |
| Almatica Pharma LLC | $15.03 | 2021 | |
| Redhill Biopharma INC. | $13.62 | 2021 | |
| Stimwave Technologies Incorporated | $11.95 | 2019 | |
| Ossur Americas, INC. | $10.85 | 2024 | Miami J |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Roslonski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.